1. Home
  2. NEON vs JSPR Comparison

NEON vs JSPR Comparison

Compare NEON & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

HOLD

Current Price

$1.70

Market Cap

27.9M

Sector

Technology

ML Signal

HOLD

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.95

Market Cap

23.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
JSPR
Founded
1997
2018
Country
Sweden
United States
Employees
N/A
22
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
23.1M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
NEON
JSPR
Price
$1.70
$0.95
Analyst Decision
Hold
Buy
Analyst Count
1
11
Target Price
$6.00
$15.50
AVG Volume (30 Days)
84.5K
567.1K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
37.88
N/A
EPS
N/A
N/A
Revenue
$3,108,000.00
N/A
Revenue This Year
$72.74
N/A
Revenue Next Year
$28.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$0.62
52 Week High
$29.90
$7.19

Technical Indicators

Market Signals
Indicator
NEON
JSPR
Relative Strength Index (RSI) 60.66 47.89
Support Level $1.69 $0.81
Resistance Level $1.74 $1.12
Average True Range (ATR) 0.10 0.10
MACD 0.02 0.01
Stochastic Oscillator 88.57 42.03

Price Performance

Historical Comparison
NEON
JSPR

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in the United States, Japan, South Korea, Germany, Sweden, China, and other regions. A majority of its revenue is generated from Japan.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: